Bybit expands its trading ecosystem with six U.S. stock perpetual contracts, giving traders 24/7 exposure to UNH, GE, JPM, GILD, AMGN, and REGN.
Bybit Broadens Stock Trading Access
Bybit has expanded its derivatives marketplace by introducing perpetual contracts linked to six leading U.S. companies, marking another step in its strategy to bridge digital assets and traditional financial markets. The latest rollout includes contracts tied to UnitedHealth Group (UNH), General Electric (GE), JPMorgan Chase (JPM), Gilead Sciences (GILD), Amgen (AMGN), and Regeneron Pharmaceuticals (REGN).
The launch enables traders to speculate on the price movements of these companies without purchasing the underlying shares. Instead, participants gain exposure through perpetual contracts, a derivatives product already familiar to cryptocurrency traders. By extending this model to major U.S. equities, Bybit is expanding the range of investment opportunities available on a single platform.
The newly listed contracts also strengthen Bybit’s growing portfolio of stock-linked products, following previous listings of sector-focused contracts tied to U.S. exchange-traded funds and other equity-based instruments. The move reflects increasing demand for trading products that combine the flexibility of crypto markets with exposure to established public companies.
How Stock Perpetual Contracts Work
Unlike conventional futures contracts, perpetual contracts have no expiration date, allowing traders to maintain positions for as long as they choose, provided margin requirements are met. Prices are designed to closely follow the underlying stock through a funding-rate mechanism that helps keep contract values aligned with market prices.
Rather than owning company shares, traders speculate on whether prices will rise or fall. This structure provides flexibility while eliminating the need to purchase the actual equity.
Key features include:
- Price exposure without owning the underlying stock.
- Ability to open both long and short positions.
- Continuous trading without contract expiry.
- Access through the same trading interface used for crypto derivatives.
- Potential for more efficient portfolio diversification.
For experienced market participants, these contracts offer additional trading strategies, while newer investors gain a simplified way to participate in the price movements of well-known U.S. companies.
Growing Demand for Hybrid Trading
Bybit’s latest product launch highlights a broader trend across digital asset exchanges as they expand beyond cryptocurrencies into traditional financial instruments. Integrating stock-linked derivatives alongside crypto products allows traders to monitor multiple asset classes from a single platform instead of switching between separate brokerage accounts.
The selection of companies spans several important sectors of the U.S. economy. UnitedHealth Group represents healthcare services, General Electric brings industrial exposure, JPMorgan Chase strengthens financial market coverage, while Gilead Sciences, Amgen, and Regeneron Pharmaceuticals provide access to leading biotechnology and pharmaceutical businesses. This diversified lineup enables traders to respond to developments across healthcare innovation, banking, manufacturing, and biotechnology.
As digital asset exchanges continue broadening their offerings, stock perpetual contracts are emerging as an important category for investors seeking around-the-clock market access. By adding six widely recognized U.S. equities, Bybit continues positioning itself as a platform where cryptocurrency trading and traditional financial market exposure increasingly converge, giving global traders greater flexibility to react to market opportunities whenever they arise.